The curious case of the HepG2 cell line: 40 years of expertise

VA Arzumanian, OI Kiseleva… - International journal of …, 2021 - mdpi.com
Liver cancer is the third leading cause of cancer death worldwide. Representing such a
dramatic impact on our lives, liver cancer is a significant public health concern. Sustainable …

Mutant p53 gain-of-function: role in cancer development, progression, and therapeutic approaches

E Alvarado-Ortiz, KG de la Cruz-López… - Frontiers in cell and …, 2021 - frontiersin.org
Frequent p53 mutations (mutp53) not only abolish tumor suppressor capacities but confer
various gain-of-function (GOF) activities that impacts molecules and pathways now regarded …

Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis

N Rivlin, R Brosh, M Oren, V Rotter - Genes & cancer, 2011 - journals.sagepub.com
Inactivation of the p53 tumor suppressor is a frequent event in tumorigenesis. In most cases,
the p53 gene is mutated, giving rise to a stable mutant protein whose accumulation is …

Wnt/β-catenin signaling as a driver of hepatocellular carcinoma progression: an emphasis on molecular pathways

M Deldar Abad Paskeh, S Mirzaei… - Journal of …, 2021 - Taylor & Francis
Liver cancers cause a high rate of death worldwide and hepatocellular carcinoma (HCC) is
considered as the most common primary liver cancer. HCC remains a challenging disease …

Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib

A Lachenmayer, C Alsinet, R Savic, L Cabellos… - Clinical cancer …, 2012 - AACR
Purpose: Hepatocellular carcinoma (HCC) is a heterogeneous cancer with active Wnt
signaling. Underlying biologic mechanisms remain unclear and no drug targeting this …

Dysregulation of growth factor signaling in human hepatocellular carcinoma

K Breuhahn, T Longerich, P Schirmacher - Oncogene, 2006 - nature.com
Dysregulation of pleiotropic growth factors, receptors and their downstream signaling
pathway components represent a central protumorigenic principle in human …

Pan-cancer pervasive upregulation of 3′ UTR splicing drives tumourigenesis

JJ Chan, B Zhang, XH Chew, A Salhi, ZH Kwok… - Nature Cell …, 2022 - nature.com
Most mammalian genes generate messenger RNAs with variable untranslated regions
(UTRs) that are important post-transcriptional regulators. In cancer, shortening at 3′ UTR …

Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells

H Yuzugullu, K Benhaj, N Ozturk, S Senturk, E Celik… - Molecular cancer, 2009 - Springer
Background β-catenin mutations that constitutively activate the canonical Wnt signaling have
been observed in a subset of hepatocellular carcinomas (HCCs). These mutations are …

Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression

K Uematsu, B He, L You, Z Xu, F McCormick… - Oncogene, 2003 - nature.com
Non small cell lung cancer (NSCLC) is the leading cause of cancer deaths in the United
States and worldwide. Unfortunately, standard therapies remain inadequate. An increased …

[图书][B] Folate in health and disease

LB Bailey - 2009 - taylorfrancis.com
During the fifteen years since the bestselling first edition of Folate in Health and Disease
was published, there have been thousands of new research studies related to folate and its …